Literature DB >> 25160013

Effects of green tea extract on serum uric acid and urate clearance in healthy individuals.

Kanon Jatuworapruk1, Somdet Srichairatanakool, Sakaewan Ounjaijean, Nuntana Kasitanon, Suparaporn Wangkaew, Worawit Louthrenoo.   

Abstract

OBJECTIVE: The objective of this study was to investigate the hypouricemic effects of green tea extract (GTE) in healthy individuals.
METHODS: This study comprised 1-week control, 2-week interventional, and 1-week follow-up periods. Participants were assigned randomly at the interventional period to consume GTE at 2 (GTE2), 4 (GTE4), or 6 (GTE6) g/d. Levels of serum uric acid (SUA), uric acid clearance, and serum antioxidant power (using trolox equivalent antioxidant capacity assay) were measured at both ends of each study period.
RESULTS: Of 30 participants, 11, 11, and 8 received GTE2, GTE4, and GTE6, respectively. After 2 weeks of consumption, the mean SUA level tended to decrease in all groups, with no statistical significance. Serum uric acid reduction was greatest in GTE2 (from 4.81 ± 0.81 mg/dL to 4.64 ± 0.92 mg/dL, 3.53%). Uric acid clearance decreased significantly in GTE2 (from 11.37 ± 6.41 mL/min per 1.73 m to 7.44 ± 2.74 mL/min per 1.73 m, 34.56%, P < 0.05) and GTE4 (from 8.36 ± 3.41 mL/min per 1.73 m to 5.78 ± 2.33 mL/min per 1.73 m, 30.86%, P < 0.05). Serum antioxidant capacity (TEAC) increased significantly in GTE6 (from 32.77 ± 3.39 mg/mL to 35.41 ± 3.17 mg/mL, 8.06%, P < 0.05). There was no significant change in creatinine clearance. Gastrointestinal adverse events were common, but usually mild, with no medical treatment required.
CONCLUSIONS: Green tea extract may modestly lower SUA level and decreases uric acid clearance. Green tea extract also significantly elevated serum antioxidant capacity with a positive dosage effect. The effect of GTE on SUA in healthy individuals was short term. The effects of GTE on urate handling in patients with hyperuricemia or gout need to be determined.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25160013     DOI: 10.1097/RHU.0000000000000148

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  8 in total

1.  Tea (Camellia sinensis) Ameliorates Hyperuricemia via Uric Acid Metabolic Pathways and Gut Microbiota.

Authors:  Dan Wu; Ruohong Chen; Qiuhua Li; Xingfei Lai; Lingli Sun; Zhenbiao Zhang; Shuai Wen; Shili Sun; Fanrong Cao
Journal:  Nutrients       Date:  2022-06-27       Impact factor: 6.706

2.  Tea consumption and serum uric acid levels among older adults in three large-scale population-based studies in China.

Authors:  Dan-Dan Chen; Xing-Xuan Dong; Xue-Jiao Yang; Hong-Peng Sun; Gang Liang; Xing Chen; Chen-Wei Pan
Journal:  BMC Geriatr       Date:  2021-04-21       Impact factor: 3.921

Review 3.  Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.

Authors:  Stefanos Roumeliotis; Athanasios Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

4.  Antioxidant therapy (lycopene and green tea extract) in periodontal disease: A promising paradigm.

Authors:  Pragya Tripathi; Vikram Blaggana; Preeti Upadhyay; Manika Jindal; Shweta Gupta; Sadaf Nishat
Journal:  J Indian Soc Periodontol       Date:  2019 Jan-Feb

5.  Tea Consumption is Associated with an Increased Risk of Hyperuricemia in an Occupational Population in Guangdong, China.

Authors:  Ruining Li; Lin Zeng; Chengkai Wu; Pengcheng Ma; Hao Cui; Liya Chen; Qimei Li; Chang Hong; Li Liu; Lushan Xiao; Wenyuan Li
Journal:  Int J Gen Med       Date:  2022-03-10

6.  EGCG Attenuates Uric Acid-Induced Inflammatory and Oxidative Stress Responses by Medicating the NOTCH Pathway.

Authors:  Hua Xie; Jianqin Sun; Yanqiu Chen; Min Zong; Shijie Li; Yan Wang
Journal:  Oxid Med Cell Longev       Date:  2015-10-11       Impact factor: 6.543

7.  Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort.

Authors:  Chong Tian; Qiao Huang; Liangle Yang; Sébastien Légaré; Francesca Angileri; Handong Yang; Xiulou Li; Xinwen Min; Ce Zhang; Chengwei Xu; Jing Yuan; Xiaoping Miao; Mei-an He; Tangchun Wu; Xiaomin Zhang
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

Review 8.  Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers.

Authors:  Yun-Ju Huang; Kai-Lee Wang; Hsin-Yuan Chen; Yi-Fen Chiang; Shih-Min Hsia
Journal:  Biomolecules       Date:  2020-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.